Search Count: 5,442
 |
Organism: Synthetic construct, Saccharomyces cerevisiae
Method: X-RAY DIFFRACTION Release Date: 2025-12-24 Classification: HYDROLASE Ligands: MG, CL, MES |
 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Release Date: 2025-12-24 Classification: HYDROLASE/INHIBITOR Ligands: SO4, YUJ |
 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Release Date: 2025-12-24 Classification: HYDROLASE/INHIBITOR Ligands: YUA, SO4 |
 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Release Date: 2025-12-24 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: YUP, SO4 |
 |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Release Date: 2025-12-17 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: A1BK4 |
 |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Release Date: 2025-12-17 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: A1BK3, GOL |
 |
Crystal Structure Of Kirsten Rat Sarcoma G12C Complexed With Gmppnp And Covalently Bound To An Adduct Of {(2S)-4-[7-(8-Chloronaphthalen-1-Yl)-2-{[(2S)-1-Methylpyrrolidin-2-Yl]Methoxy}-5,6,7,8-Tetrahydropyrido[3,4-D]Pyrimidin-4-Yl]-1-[(2Z)-2-Fluoro-3-(Pyridin-2-Yl)Prop-2-Enoyl]Piperazin-2-Yl}Acetonitrile
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-11-05 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: GNP, A1B7P, MG |
 |
Crystal Structure Of Kirsten Rat Sarcoma G12C Complexed With Gdp And Covalently Bound To An Adduct Of (2S)-1-{4-[(7P)-7-(8-Ethynyl-7-Fluoro-3-Hydroxynaphthalen-1-Yl)-8-Fluoro-2-{[(2R,4R,7As)-2-Fluorotetrahydro-1H-Pyrrolizin-7A(5H)-Yl]Methoxy}Pyrido[4,3-D]Pyrimidin-4-Yl]Piperazin-1-Yl}-2-Fluoro-3-(1,3-Thiazol-2-Yl)Propan-1-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-11-05 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: GDP, A1B7Q, MG |
 |
Crystal Structure Of Wild-Type Egfr In Complex With The Reversible Inhibitor Sevabertinib (Bay 2927088)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-10-15 Classification: TRANSFERASE Ligands: SIN, CL, DMS, EDO, A1JBI |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-09-24 Classification: HYDROLASE Ligands: GOL, DMS, FLC, P3G, PEG |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-09-24 Classification: HYDROLASE Ligands: FLC |
 |
 |
Room-Temperature X-Ray Structure Of Sars-Cov-2 Main Protease In Complex With Inhibitor Bbh-3
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Release Date: 2025-07-30 Classification: VIRAL PROTEIN,HYDROLASE/HYDROLASE INHIBITOR Ligands: A1B20 |
 |
Room-Temperature X-Ray Structure Of Sars-Cov-2 Main Protease In Complex With With Inhibitor Bbh-4
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Release Date: 2025-07-30 Classification: VIRAL PROTEIN,HYDROLASE/HYDROLASE INHIBITOR Ligands: A1B21 |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-07-23 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: GNP, MG, A1AZX, CL |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-07-23 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: GNP, MG, CL, A1AZY |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-07-23 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: GNP, MG, A1AZW |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Release Date: 2025-07-23 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: GNP, MG, CL, A1AZZ |
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro)In Complex With Inhibitor Avi-3318
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Release Date: 2025-07-23 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: A1BTM |
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro)In Complex With Inhibitor Avi-4516
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Release Date: 2025-07-23 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: A1BTP, EDO |